Skip to main content


Edited by Allen Everett,Vera Ignjavtovic,and Hanno Steen

The Paediatric Proteomics (PediOme) is an initiative of HUPO that aims to advance the use of proteomic techniques to solve major issues in Paediatric medicine by:

i) Characterization of the paediatric proteome across a wide-variety of tissues and biological samples.
ii) Improving the current knowledge of the pathophysiology of childhood diseases.
iii) Facilitate training, communication and collaborations between scientists, clinicians and the industry across all parts of the globe in the areas of interest specific to child health and disease. 

This review series published in Clinical Proteomics highlights the work done by scientists working on the PediOme.

This collection of articles has not been sponsored and articles have undergone the journal's standard peer-review process. The Guest Editors declare no competing interests.

  1. Treatment for glaucoma has traditionally been limited to reducing intraocular pressure (IOP). Inhibiting oxidative stress in the trabecular meshwork (TM) is regarded as a new treatment for glaucoma; however, t...

    Authors: Qian Li, Liyu Zhang and Yuxin Xu
    Citation: Clinical Proteomics 2022 19:12
  2. Assessments of disease progression and response to therapies in Duchenne muscular dystrophy (DMD) patients remain challenging. Current DMD patient assessments include complex physical tests and invasive proce...

    Authors: Yetrib Hathout, Haeri Seol, Meng Hsuan J. Han, Aiping Zhang, Kristy J. Brown and Eric P. Hoffman
    Citation: Clinical Proteomics 2016 13:9
  3. X-linked muscular dystrophy is a primary disease of the neuromuscular system. Primary abnormalities in the Dmd gene result in the absence of the full-length isoform of the membrane cytoskeletal protein dystrophin...

    Authors: Sandra Murphy, Margit Zweyer, Michael Henry, Paula Meleady, Rustam R. Mundegar, Dieter Swandulla and Kay Ohlendieck
    Citation: Clinical Proteomics 2015 12:27